Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2851-2855

  Wang, Qing Mei ^a   Luo, Xun ^a   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLIN DEPENDENT KINASE; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN HL 60; DRUG EFFECT; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CALCITRIOL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; G1 PHASE; HL-60 CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030787931     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-tree conditions. J. Invest. Dermatol., 86: 709-714, 1984.
2. Studzinski, G. P., and Moore, D. C. Vitamin D and retardation of cancer progression. In: R. R. Watson and S. I. Mufti (eds.), Nutrition and Cancer Prevention, pp 257-282. Boca Raton, FL: CRC Press, 1995.
3. 3 inhibits proliferation of human promyelocytic leukemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leukemia Res., 7: 51-55, 1983.
4. Studzinski, G. P., McLane, J. A., and Uskokovic, M. R. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryotic Gene Expression, 4: 279-312, 1993.
5. 3. Cell Proliferation, 27: 37-46, 1994.
6. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Hubertman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 3397-3406, 1994.
7. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travail, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
8. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., and Freedman, L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes & Dev., 10: 142-153, 1996.
9. 3 in HL60 cells. Cancer Res., 56: 264-267, 1996.
10. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. Cloning of p27/Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
11. 3. Exp. Cell Res., 224: 312-322, 1996.
12. Won, K. A., Xiong, Y. Beach, D., and Gilman, M. Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 9910-9914, 1992.
13. Sherr, C. I. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
14. 1-to-S transition in mammalian cells. Oncogene, 8: 1593-1602, 1993.
15. 1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1694, 1992.
16. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
17. Kip1 accumulation during the cell cycle. Science (Washington DC), 271: 1861-1864, 1996.
18. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4. Genes & Dev., 7: 331-342, 1993.
19. Mittnacht, S., Lees, J. A., Desai, D., Harlow, E., Morgan, D. O., and Weinberg, R. A. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J., 13: 118-127, 1996.
20. Dou, Q. P., Levin, A. H., Zhao, S., and Pardee, A. B. Cyclin E and Cyclin A as candidates for the restriction point protein. Cancer Res., 53: 1493-1497, 1993.
21. Geng, Y., Eaton, E. N., Picon, M., Roberts, J. M., Lundberg, A. S., Gifford, A., Sardet, C., and Weinberg, R. A. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene, 12: 1173-1180, 1996.
22. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
23. Studzinski, G. P., and Brelvi, Z. S. Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL60 cells. J. Natl. Cancer Inst., 79: 67-76, 1987.
24. Reynisdottir, I., Polyak, K., Lavarone, A., and Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β Genes & Dev., 9: 1831-1845, 1995.
25. Agrawal, D., Dong, H., Wang, Y. X., Kada, D., and Pledger, W. J. Regulation of cyclin E and p27/Kip1 during mitosis in BALB/c 373 cells. Cell Growth & Differ., 6: 1199-1205, 1995.
26. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M. Interleukin-2-mediated elimination of the p27/Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
27. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., and Ross, R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell, 87: 1069-1078, 1996.
28. INKB tumor suppressor and immunoglobulin heavy chain genes: TGFβ/IL-7 inhibitory signaling mechanism. Leukemia (Baltimore), 10: 1576-1583, 1996.
29. Kuniyasu, H., Yasui, W., Kitahara, K., Naka, K., Yokiozaki, H., Akama, Y., Hamamoto, T., Tahara, H., and Tahara, E. Growth inhibitory effect of interferon-β is associated with the induction of cyclin-dependent kinase inhibitor p27 in a human gastric carcinoma cell line. Cell Growth & Differ., 8: 47-52, 1997.